HCP5 and breast cancer: Lee et al. showed first evidence describing the function of special AT-rich sequence binding protein 1 (SATB1) in lncRNA transcription including HCP5. SATB1 was found to be highly expressed in aggressive breast cancer, and it also enhanced HCP5 in these cells [146].